Cart
sales@molnova.com
RGFP966
CAS No. 1396841-57-8
RGFP966( —— )
Catalog No. M11656 CAS No. 1396841-57-8
RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 75 | In Stock |
|
| 50MG | 105 | In Stock |
|
| 100MG | 160 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRGFP966
-
NoteResearch use only, not for human use.
-
Brief DescriptionRGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay.
-
DescriptionRGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
Recptor——
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1396841-57-8
-
Formula Weight362.4
-
Molecular FormulaC21H19FN4O
-
Purity>98% (HPLC)
-
SolubilityN/A
-
SMILESC1=CC=C(C=C1)C=CCN2C=C(C=N2)C=CC(=O)NC3=C(C=C(C=C3)F)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1 Malvaez M, et al. PnaS, 2013, 110(7), 2647-2652.
molnova catalog
related products
-
NCC-149
A potent and selective HDAC8 inhibitor with IC50 of 70 nM.
-
Ledipasvir
Ledipasvir is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of ledipasvir is as a P-Glycoprotein Inhibitor, and Breast Cancer Resistance Protein Inhibitor.
-
M 344
M344 is a potent HDAC inhibitor with IC50 of 100 nM and able to induce cell differentiation.
